A combination therapy (CT) of LL-PINS+IL-10 with a short-course of subtherapeutic doses anti-CD3 Abs reversed diabetes in 59% of treated mice in comparison to 25% with anti-CD3 monotherapy and 15% when using LL-PINS+IL-10 alone. Here, IL10 is linked to diabetes mellitus.